BioMaxima Overview

  • Founded
  • 2002
Founded
  • Status
  • Public
  • Employees
  • 98
Employees
  • Stock Symbol
  • BMX
Stock Symbol
  • Investments
  • 6
  • Share Price
  • $7.24
  • (As of Friday Closing)

BioMaxima General Information

Description

Biomaxima SA is a Polish company, produces microbiology media as well as a wide range of reagents and in Vitro diagnostics equipment. The company is also a distributor of products of recognized global diagnostics companies such as Nova Biomedical, Mitsubishi Chemical and Biologist. Its products include Systems Antibiotic Susceptibility Testing, Urine Analysis Systems, Hematological Reagents along with Analyzers, ion Selective Analyzers with Reagents, Immunological Analyzer of Cardiac markers with reagents, Glucose Meters and analyzers for Gasometric and Critical Blood Tests.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Stock Exchange
WAR
Primary Office
  • Spółka Akcyjna ul.
  • Vetterów 5
  • Lublin, 20-277
  • Poland
+48 81 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioMaxima Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.24 $7.18 $6.66 - $15.71 $31M 4.32M 6.22K $0.67

BioMaxima Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 32,560 34,026 6,829 7,934
Revenue 21,061 15,798 7,941 8,528
EBITDA 3,996 2,781 585 292
Net Income 2,904 1,888 (4) (133)
Total Assets 13,113 14,339 11,398 11,683
Total Debt 2,419 3,089 3,186 4,182
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BioMaxima Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioMaxima‘s full profile, request access.

Request a free trial

BioMaxima Executive Team (2)

Name Title Board Seat Contact Info
Lukasz Urban Chief Executive Officer & President
Henry Lewczuk Vice President
To view BioMaxima’s complete executive team members history, request access »

BioMaxima Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioMaxima Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 000000 28-Nov-2016 000000000000000000 00000 Biotechnology 00000 0000000
0000 000 23-Nov-2016 000000000000000000 Medical Supplies
00000 15-Jun-2016 000000000000000000 Diagnostic Equipment
0000 000000 31-Mar-2013 000000000000000000 Commodity Chemicals 00000 0000000
Emapol 27-Jun-2012 Merger/Acquisition 00.000 Diagnostic Equipment 00000 0000000
You’re viewing 5 of 6 acquisitions. Get the full list »

BioMaxima Subsidiaries (1)

Company Name Industry Location Founded
0000000 000000 Biotechnology Warszawa, Poland 0000
To view BioMaxima’s complete subsidiaries history, request access »